Hasil Filter

2279

Total database: 17430
Struktur (SMILES)
866 (38.0%)
Target
1100 (48.3%)
Genomik
31 (1.4%)
Referensi
2279 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (2279)

Halaman 45 / 46
Vigabatrin Approved DB01080
small molecule | CAS: 68506-86-5

Vigabatrin is an analog of gamma-aminobutyric acid ([GABA]), the main inhibitory neurotransmitter in the central nervous system, used in the treatment of refractory seizures and infantile spasms.[L13616] It irreversibly inhibits the enzyme responsible for GAB…

Kategori:
Acids, AcyclicAminobutyratesAnti-epileptic Agent +15
Target Protein:
4-aminobutyrate aminotransferase, mitochondrial
Waktu ParuhThe terminal half-l…
Vol. DistribusiVigabatrin is widel…
KlirensThe oral clearance …
Genetik -
Vilamakitug DB18978
biotech | CAS: 2458202-06-5

Vilamakitug is under investigation in clinical trial NCT05201352 (Evaluation of Efficacy of Trifluridine/tipiracil Plus an Anti-il-1? True Human Antibody Versus Trifluridine/tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxal…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vilastobart DB19327
biotech | CAS: 2760549-50-4

Vilastobart is under investigation in clinical trial NCT04896697 (Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vildagliptin Approved DB04876
small molecule | CAS: 274901-16-5

Vildagliptin (LAF237) is an orally active antihyperglycemic agent that selectively inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme. It is used to manage type II diabetes mellitus, where GLP-1 secretion and insulinotropic effects are impaired.[A232488] By i…

Kategori:
Agents causing angioedemaAlimentary Tract and MetabolismBlood Glucose Lowering Agents +11
Target Protein:
Dipeptidyl peptidase 4
Waktu ParuhThe mean eliminatio…
Vol. DistribusiThe mean volume of …
KlirensAfter intravenous a…
Genetik -
Vilobelimab DB16416
biotech | CAS: 2250440-41-4

Vilobelimab is a chimeric monoclonal immunoglobulin G4 (IgG4) antibody that binds to the soluble form of human C5a with high affinity. It consists of mouse anti-human complement factor 5a (C5a) monoclonal binding sites (variable regions of heavy and light cha…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +10
Target Protein:
Complement C5
Waktu ParuhThe elimination hal…
Vol. DistribusiNo information is a…
KlirensNo information is a…
Genetik -
Viltolarsen Approved DB15005
biotech | CAS: 2055732-84-6

Duchenne muscular dystrophy (DMD) is an X-linked recessive allelic disorder characterized by a lack of functional dystrophin protein, which leads to progressive ambulatory, pulmonary, and cardiac function and is invariably fatal. A related, albeit a less seve…

Kategori:
Antisense OligonucleotidesMorpholinesMusculo-Skeletal System +5
Target Protein:
DMD gene (exon 53 viltolarsen target site)
Waktu ParuhViltolarsen has a r…
Vol. DistribusiViltolarsen has a s…
KlirensViltolarsen has a r…
Genetik -
Vincristine Approved DB00541
small molecule | CAS: 57-22-7

Vincristine is an antitumor vinca alkaloid isolated from Vinca Rosea. It is marketed under several brand names, many of which have different formulations such as Marqibo (liposomal injection) and Vincasar. Vincristine is indicated for the treatment of acute l…

Kategori:
Agents Causing Muscle ToxicityAlkaloidsAntimitotic Agents +33
Target Protein:
Tubulin beta chainTubulin alpha-4A chain
Waktu ParuhWhen intravenously …
Vol. DistribusiWithin 15 to 30 min…
Klirens-
Genetik -
Vinflunine Approved DB11641
small molecule | CAS: 162652-95-1

Vinflunine is a third-generation member of the vinca alkaloid family with anti-tumour actions. It was first described in 1998 at the Pierre Fabre research center in France. Like other vinca agents, vinflunine is an anti-mitotic agent that induces a cell cycle…

Kategori:
AlkaloidsAntineoplastic AgentsAntineoplastic and Immunomodulating Agents +14
Target Protein:
Tubulin beta chain
Waktu ParuhThe mean terminal h…
Vol. DistribusiThe terminal volume…
KlirensThe total blood cle…
Genetik -
Viper antivenom Approved DB14114
biotech

Viper antivenom consists of antibodies derived from horses immunized and subsequently developed antibodies against snake venoms. ANAVIP, an equine-derived antivenom made with venom from _Bothrops asper_ and _Crotalus durissus_, was first approved by the FDA o…

Kategori:
Antivenins
Waktu ParuhFollowing intraveno…
Vol. DistribusiFollowing intraveno…
KlirensFollowing intraveno…
Genetik -
biotech

Viral macrophage inflammatory protein-II (vMIP) is a highly basic protein and human chemokine analog encoded by human herpesvirus-8. The structure of vMIP consists of 71 residues and is a monomer under most conditions. It helps its virus evade the host immune…

Kategori:
Amino Acids, Peptides, and ProteinsAnti-HIV AgentsAnti-Infective Agents +10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Viralym-C DB17975
biotech

Viralym-C is an investigational T-cell immunotherapy developed by ViraCyte. It consists of Human Leukocyte Antigen (HLA)-matched cytomegalovirus (CMV)-specific T lymphocytes. It was granted FDA orphan designation in January 2017 and investigated for the treat…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VIS-410 DB19067
biotech | CAS: 2043950-09-8

VIS-410 is under investigation in clinical trial NCT03040141 (Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vitamin D Approved DB11094
small molecule | CAS: 1406-16-2

Vitamin D ultimately comprises a group of lipid-soluble secosteroids responsible for a variety of biological effects, some of which include increasing the intestinal absorption of calcium, magnesium, and phosphate. With reference to human use, there are 2 mai…

Kategori:
Bone Density Conservation AgentsCytochrome P-450 CYP3A SubstratesCytochrome P-450 CYP3A4 Substrates +12
Target Protein:
Vitamin D3 receptorVitamin D-binding protein
Waktu ParuhAlthough certain st…
Vol. Distribusi-
KlirensSome studies propos…
Genetik -
Vitespen DB06400
biotech | CAS: 492448-75-6

Deskripsi belum tersedia.

Kategori:
Amino Acids, Peptides, and ProteinsBiological ProductsComplex Mixtures +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Vitex agnus-castus fruit extract is obtained from dry fruits of Vitex agnus-castus. The fruits contain mixture of iridoids, flavonoids and compounds in leaves and flowers that structurally resemble sex hormones. Clinical studies demonstrates effectiveness of …

Kategori:
AngiospermsBiological ProductsComplex Mixtures +12
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vixarelimab DB16350
biotech | CAS: 2243320-83-2

Vixarelimab is under investigation in clinical trial NCT03816891 (A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Voclosporin Approved DB11693
small molecule | CAS: 515814-01-4

Lupus nephritis (LN) is a type of glomerulonephritis occurring in patients with systemic lupus erythematosus (SLE). LN is a significant cause of renal failure, morbidity, and death in patients with SLE. Within 10 years of being diagnosed with SLE, 5-20% of …

Kategori:
Amino Acids, Peptides, and ProteinsAntineoplastic and Immunomodulating AgentsCalcineurin Inhibitor Immunosuppressant +16
Target Protein:
Guided entry of tail-anchored proteins factor CAMLGProtein phosphatase 3 catalytic subunit alphaCalcineurin subunit B type 1 +1
Waktu ParuhThe average termina…
Vol. DistribusiThe apparent volume…
KlirensThe mean apparent s…
Genetik -
Volixibat DB13914
small molecule | CAS: 1025216-57-2

Volixibat, also known as SHP626 or LUM002, is an investigational drug that will potentially be used for the treatment of Non-Alcoholic Steatohepatitis (NASH). If approved for use, it will be the first available agent for the treatment of NASH. Volixibat is…

Kategori:
CarbohydratesHeterocyclic Compounds, Fused-RingLipid Regulating Agents +1
Target Protein:
Ileal sodium/bile acid cotransporter
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Von Willebrand factor human Approved DB13133
biotech | CAS: 109319-16-6

The human von Willebrand factor (vWF) is a human plasma-derived vWF, an endogenous large multimeric plasma glycoprotein involved in hemostasis. It serves a dual role in hemostasis by mediating platelet adhesion and aggregation at the site of blood vessel inju…

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsBlood and Blood Forming Organs +8
Target Protein:
Coagulation factor VIIICollagen alpha-1(I) chainAsialoglycoprotein receptor 1 +1
Waktu ParuhIn patients with Ty…
Vol. DistribusiThe volume of distr…
KlirensIn patients with Ty…
Genetik -
Vonicog alfa Approved DB12872
biotech

Vonicog alfa is a recombinant human von Willebrand factor (rVWF) produced from Chinese hamster ovary cells.[A264444] Used to treat von Willebrand Disease (vWD), it mimics the biological actions of endogenous VWF,[L51274] which is a critical plasma glycoprotei…

Kategori:
von Willebrand Factor
Target Protein:
Coagulation factor VIIICollagen alpha-1(I) chain
Waktu ParuhIn Study 071001, th…
Vol. Distribusi-
KlirensIn Study 071001, th…
Genetik -
Vonlerolizumab DB16352
biotech | CAS: 1638935-72-4

Vonlerolizumab is under investigation in clinical trial NCT03029832 (A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cispl…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodies, MonoclonalAntibodies, Monoclonal, Humanized +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Voretigene neparvovec Approved DB13932
biotech | CAS: 1646819-03-5

Voretigene Neparvovec-rzyl (VN-rzyl) is an adeno-associated virus vector-based gene therapy.[L1094] An adeno-associated virus is a small virus that infects humans and other primates. It is not pathogenic and it causes a very mild immune response. This type of…

Kategori:
Adeno-associated Viral Vector TherapiesOphthalmologicalsSensory Organs
Target Protein:
Retinoid isomerohydrolase
Waktu ParuhBased on the pharma…
Vol. DistribusiVN-rzyl was shown t…
KlirensAccording to the ki…
Genetik -
Vortioxetine Approved DB09068
small molecule | CAS: 508233-74-7

Vortioxetine is an antidepressant medication indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and stimulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotransmitter syste…

Kategori:
Agents that produce hypertensionAnti-Anxiety AgentsAntidepressive Agents +30
Target Protein:
Sodium-dependent serotonin transporter5-hydroxytryptamine receptor 3A5-hydroxytryptamine receptor 7 +4
Waktu ParuhMean terminal half­…
Vol. DistribusiThe apparent volume…
Klirens-
Genetik -
Vosoritide Approved DB11928
biotech | CAS: 1480724-61-5

Achondroplasia is an autosomal dominant genetic disease and the most common cause of dwarfism in humans.[A242277] It results from a gain-of-function missense mutation in _FGFR3_ that results in a dramatic suppression of bone growth, both in volume and in leng…

Kategori:
Amino Acids, Peptides, and ProteinsC-type Natriuretic Peptide AnalogDrugs Affecting Bone Structure and Mineralization +7
Target Protein:
Atrial natriuretic peptide receptor 2
Waktu ParuhThe mean half-life …
Vol. DistribusiThe mean apparent v…
KlirensThe mean apparent c…
Genetik -
VPM1002 DB15801
biotech

The bacille Calmette-Guérin (BCG) vaccine protects against severe extrapulmonary forms of tuberculosis (TB) but does not adequately protect against pulmonary TB -- the most prevalent form of TB. This recombinant BCG, VPM1002, has been created in response and …

Kategori:
Bacterial VaccinesBiological ProductsComplex Mixtures +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VPM4001 DB05089
biotech

VPM4001 is an allogeneic vaccine for treatment of prostate carcinoma. It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete interferon-? and interleukin-2 (LNCaP/IL-2/IFN-?). Interferon-? enhances presentation …

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Wortmannin DB08059
small molecule | CAS: 19545-26-7

Wortmannin is a steroid metabolite of _Penicillium funiculosum_ and _Talaromyces wortmannii_ fungi. This drug acts as a nonspecific, covalent inhibitor of phosphoinositide 3-kinase enzymes (PI3Ks).

Kategori:
AndrostadienesAndrostanesAndrostenes +16
Target Protein:
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformSerine/threonine-protein kinase PLK1 +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
WU-CART-007 DB18617
biotech

WU-CART-007 consists of allogeneic, fratricide-resistant genetically modified T cells transduced with a 2nd generation 4-1BB-CD3z chimeric antigen receptor targeting human CD7.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Xaluritamig DB18137
biotech

Xaluritamig is a novel humanized bispecific T cell recruiting antibody cross-reactive to human and nonhuman primate STEAP1 and CD3.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Xanthan gum Approved DB11253
small molecule | CAS: 11138-66-2

Xanthan gum is a polysaccharide gum derived from* Xanthomonas campestris* by a pure-culture fermentation process and purified by recovery with isopropyl alcohol. The major constituents include D-glucose, D-mannose, and D-glucuronic acid. Xanthan gum is a dire…

Kategori:
AntigensAntigens, BacterialBiological Factors +9
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
XAV-19 DB15895
biotech

XAV-19 is an intravenous antibody-based treatment targeted towards SARS-CoV-2 and other coronaviruses[L16553,L16558]. The therapy concept is based on [COVID-19 convalescent plasma]. However, rather than using human plasma, XAV-19 is a heterologous swine glyco…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesBlood Proteins +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Xeligekimab DB18869
biotech | CAS: 2382921-73-3

Xeligekimab is under investigation in clinical trial NCT06028490 (A Study of Il4r? Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ximelagatran Approved DB04898
small molecule | CAS: 192939-46-1

Ximelagatran is an anticoagulant intended to become a replacement for warfarin by overcoming the dietary restrictions, drug interaction, and monitoring issues associated with the former. In 2006, its manufacturer AstraZeneca announced that it would not attemp…

Kategori:
AminesAnticoagulantsAntithrombins +10
Target Protein:
Prothrombin
Waktu Paruh3-5 hours
Vol. Distribusi-
Klirens-
Genetik -
XL281 DB05190
small molecule

XL281 is a novel anticancer compound designed to potently inhibit the RAS/RAF/MEK/ERK signaling pathway. Mutational activation of RAS occurs in about 30 percent of all human tumors, including non-small cell lung, pancreatic, and colon cancer. XL281 is a speci…

Target Protein:
Serine/threonine-protein kinase B-rafRAF proto-oncogene serine/threonine-protein kinase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
XL820 DB05146
small molecule | CAS: 1123889-88-2

XL820 is investigated for use/treatment in solid tumors. XL820 is a solid. The proteins that XL820 inhibit include platelet-derived growth factor receptor beta (PDGFR), mast/stem cell growth factor receptor KIT, vascular endothelial growth factor receptor 2, …

Target Protein:
Vascular endothelial growth factor receptor 2Mast/stem cell growth factor receptor KitPlatelet-derived growth factor receptor alpha +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
XmAb 2513 DB06324
biotech

XmAb 2513 is a humanized monoclonal antibody that targets the antigen CD30, a molecule expressed on the surface of a number of tumor cell types. It has been investigated for the treatment of hodgkin’s lymphoma.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Target Protein:
Tumor necrosis factor receptor superfamily member 8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
XMT-1001 DB06069
small molecule

XMT-1001 is a polymer-based prodrug of camptothecin (CPT), a well-characterized topoisomerase I inhibitor with potent anti-tumor activity. It is a water-soluble macromolecular conjugate of camptothecin (CPT). In this novel CPT pro-drug, CPT is conjugated with…

Kategori:
AcetalsAlkaloidsCompounds used in a research, industrial, or household setting +1
Target Protein:
DNA topoisomerase 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
XP21279 DB06319
small molecule

XP21279 is a prodrug of [Levodopa], a dopamine precursor used in the management of Parkinson's disease. XP21279 was under investigation in clinical trial NCT00914602 (An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects…

Target Protein:
Aromatic-L-amino-acid decarboxylase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
XPro1595 DB16454
biotech | CAS: 2489785-77-3

XPro1595 is an investigational dominant-negative protein that neutralizes soluble TNF.

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsBlood Proteins +10
Target Protein:
Tumor necrosis factor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
XTL-6865 DB06058
small molecule

XTL-6865 is a combination of two fully human monoclonal antibodies (Ab68 and Ab65) against the hepatitis C virus E2 envelope protein. It is being developed to prevent HCV re-infection following a liver transplant and for the treatment of chronic HCV disease.

Target Protein:
Genome polyprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Xylazine DB11477
small molecule | CAS: 7361-61-7

Xylazine is a clonidine analog used as a non-opioid tranquilizer in veterinary medicine and as an emetic, especially in cats.[A9095,L42675,A251420] It acts as an agonist at ?2 adrenoceptors; however, its affinity is lower than the one reported for other ?2 ad…

Kategori:
Adrenergic AgentsAdrenergic AgonistsAdrenergic alpha-2 Receptor Agonists +15
Target Protein:
Alpha-2B adrenergic receptorAlpha-2C adrenergic receptorAlpha-2 adrenergic receptors
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Xylitol DB11195
small molecule | CAS: 87-99-0

Xylitol is a naturally occurring five-carbon sugar alcohol found in most plant material, including many fruits and vegetables. Xylitol-rich plant materials include birch and beechwood [A22081]. It is widely used as a sugar substitute and in "sugar-free" food …

Kategori:
AlcoholsCarbohydratesCompounds used in a research, industrial, or household setting +8
Target Protein:
Xylose isomeraseXylose isomeraseXylose isomerase +2
Waktu ParuhNo pharmacokinetic …
Vol. DistribusiNo pharmacokinetic …
KlirensNo pharmacokinetic …
Genetik -
Xylose Approved DB09419
small molecule | CAS: 58-86-6

Xylose is a monosaccharide of the aldopentose type consisted of five carbon atoms and an aldehyde functional group. Xylose is a sugar isolated from wood. D-Xylose is a sugar widely used as a diabetic sweetener in food and beverage. Xylose has also been used a…

Kategori:
CarbohydratesMonosaccharidesPentoses
Waktu ParuhThe elimination hal…
Vol. DistribusiThe volume of distr…
KlirensThe renal clearance…
Genetik -
Yellow fever vaccine Approved DB10805
biotech

Yellow fever vaccine prevents against Yellow Fever, a viral hemorrhagic disease caused by the transmission of a _flavivirus_ through the bite of an infected mosquito. Symptoms of Yellow fever can range from asymptomatic, to mild flu-like illness, to more seve…

Kategori:
Actively Acquired ImmunityAntiinfectives for Systemic UseBiological Products +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zafiride DB18371
biotech

Zafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zalifrelimab DB15632
biotech | CAS: 2148321-69-9

Zalifrelimab is under investigation in clinical trial NCT03894215 (Phase 2 Study of Anti-pd-1 Independently or in Combination With Anti-ctla-4 in Second-line Cervical Cancer).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zalutumumab DB12202
biotech | CAS: 667901-13-5

Zalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). Zalutumumab has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +8
Target Protein:
Epidermal growth factor receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zamerovimab DB17766
biotech | CAS: 2419087-87-7

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zanidatamab Approved DB15471
biotech | CAS: 2169946-15-8

Zanidatamab is a bispecific antibody that binds two non-overlapping sites of HER2 (ERBB2).[A264718] It has been investigated for the treatment of HER2-positive solid tumors, including gastroesophageal, colorectal, and biliary tract cancers.[A264718] In No…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +9
Target Protein:
Receptor tyrosine-protein kinase erbB-2
Waktu ParuhBased on population…
Vol. DistribusiBased on population…
KlirensBased on population…
Genetik -
Menampilkan 2201–2250 dari 2279
Sebelumnya Halaman 45 / 46 Berikutnya